Literature DB >> 3413658

Is ERCP manometry useful in the choice of treatment of stones of the common bile duct?

L Masoni1, R V Buccino, G Miscusi, A Montori.   

Abstract

To verify the appropriateness of sphincterotomy as the treatment of choice of choledocholithiasis, since 1980 we have been using endoscopic retrograde cholangiopancreatographic (ERCP) manometry of the sphincter of Oddi (SO). This method allows direct investigation of SO motor activity and provides useful information regarding the presence of benign papillary stenosis (BPS). Thirty-four patients were investigated because the radiological examination indicated BPS might be present. Of these, 20 had common bile duct (CBD) stones, while the remaining 14 presented with biliarylike pain and one or more of the following: CBD dilation (larger than 12 mm); emptying of the ERCP contrast medium took longer than 45 min; abnormal liver function tests. Moreover, 8 healthy volunteers served as controls. Our results show that the incidence of SO motor anomalies is very low in the presence of choledocholithiasis, while it is substantial in patients with suspected SO dysfunction. These observations would suggest that, unlike the traditional view, BPS is rarely secondary to biliary lithiasis. Therefore, most of the sphincterotomies performed that are based on the assumption of underlying SO pathology should be considered unnecessary. Under these circumstances, the physiological role of a functioning SO has induced us to advocate sphincterotomy, surgical or endoscopic, in selected cases only.

Entities:  

Mesh:

Year:  1988        PMID: 3413658     DOI: 10.1007/bf00704351

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  9 in total

1.  Manometric evaluation of the papillar of Vater.

Authors:  O T Nebel
Journal:  Gastrointest Endosc       Date:  1975-02       Impact factor: 9.427

2.  Papillitis and stenosis of the sphincter of Oddi.

Authors:  G L Nardi
Journal:  Surg Clin North Am       Date:  1973-10       Impact factor: 2.741

3.  [Current state of surgical and endoscopic sphincterectomy].

Authors:  M Carboni; P Negro; D Tuscano; G Flati; D Flati; S Guadagni; B Porowska
Journal:  Minerva Chir       Date:  1983-11-15       Impact factor: 1.000

4.  Manometric study of the sphincter of Oddi in patients with and without common bile duct stones.

Authors:  E De Masi; E Corazziari; F I Habib; B Fontana; V Gatti; G F Fegiz; A Torsoli
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

5.  Sphincter of Oddi motor activity: a comparison between patients with common bile duct stones and controls.

Authors:  J Toouli; J E Geenen; W J Hogan; W J Dodds; R C Arndorfer
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

6.  Pressure measurements in the biliary and pancreatic duct systems in controls and in patients with gallstones, previous cholecystectomy, or common bile duct stones.

Authors:  A Csendes; A Kruse; P Funch-Jensen; M J Oster; J Ornsholt; E Amdrup
Journal:  Gastroenterology       Date:  1979-12       Impact factor: 22.682

7.  Manometric disorders in patients with suspected sphincter of Oddi dysfunction.

Authors:  J Toouli; I C Roberts-Thomson; J Dent; J Lee
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

8.  Endoscopic pancreatic and biliary manometry in pancreatic, biliary, and papillary disease, and after endoscopic sphincterotomy and surgical sphincteroplasty.

Authors:  J A Gregg; D L Carr-Locke
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

9.  Pressures in the sphincter of Oddi in patients with gallstones, common duct stones, and recurrent pancreatitis.

Authors:  M Guelrud; S Mendoza; S Vicent; M Gomez; B Villalta
Journal:  J Clin Gastroenterol       Date:  1983-02       Impact factor: 3.062

  9 in total
  1 in total

1.  Sphincter of Oddi motility in patients with bile duct stones. A comparative study using percutaneous transhepatic manometry.

Authors:  N Yuasa; Y Nimura; A Yasui; Y Akita; K Odani
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.